SynthesisFrontiers in cardiovascular medicine2024
Meta-analysis of a controlled study of levosimendan combined with Sacubitril/Valsartan for the treatment of heart failure with reduced ejection fraction in China.
Che Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.